GlycoFi is a bio tech firm that develops bio-therapeutics based on the glycan optimization technology.
GlycoFi is a biotech firm that develops biotherapeutics based on the glycan optimization technology. The firm aims to develop its own pipeline of therapeutic proteins and team with other drug-makers to develop products.GlycoFi has developed a protein manufacturing process using yeast-based glycolysation where the resulting proteins can be used in drug development.GlycoFi was incorporated in 2000 and is based in Lebanon, New Hampshire. As of June 6, 2006, GlycoFi, Inc. operates as a subsidiary of Merck & Co. Inc.